SAPONARA, MARISTELLA
 Distribuzione geografica
Continente #
NA - Nord America 5.142
EU - Europa 3.124
AS - Asia 2.701
AF - Africa 326
SA - Sud America 174
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.478
Nazione #
US - Stati Uniti d'America 5.090
SG - Singapore 1.022
CN - Cina 787
GB - Regno Unito 700
IT - Italia 675
SE - Svezia 368
DE - Germania 354
VN - Vietnam 343
HK - Hong Kong 213
IN - India 182
RU - Federazione Russa 174
CH - Svizzera 146
FR - Francia 140
IE - Irlanda 134
BR - Brasile 101
TG - Togo 98
CI - Costa d'Avorio 89
UA - Ucraina 82
NL - Olanda 81
ZA - Sudafrica 70
EE - Estonia 58
FI - Finlandia 54
CA - Canada 32
SC - Seychelles 32
AT - Austria 31
AR - Argentina 30
NG - Nigeria 30
BG - Bulgaria 28
JP - Giappone 26
BE - Belgio 25
JO - Giordania 24
PL - Polonia 24
ID - Indonesia 21
KR - Corea 21
IR - Iran 13
EC - Ecuador 12
CL - Cile 11
MX - Messico 11
AU - Australia 9
ES - Italia 8
GR - Grecia 8
MY - Malesia 8
PE - Perù 8
TR - Turchia 7
HR - Croazia 6
IQ - Iraq 5
LT - Lituania 5
NI - Nicaragua 5
UZ - Uzbekistan 5
BD - Bangladesh 4
CO - Colombia 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
EG - Egitto 4
IL - Israele 4
LB - Libano 4
NO - Norvegia 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
VE - Venezuela 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
GY - Guiana 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
PY - Paraguay 1
SA - Arabia Saudita 1
SI - Slovenia 1
TH - Thailandia 1
TW - Taiwan 1
Totale 11.478
Città #
Singapore 684
Southend 645
Ashburn 595
Fairfield 576
Chandler 455
Wilmington 282
Woodbridge 278
Houston 257
Seattle 235
Hong Kong 205
Cambridge 194
Ann Arbor 187
Princeton 173
Santa Clara 162
Bologna 148
Beijing 146
Bern 139
Dublin 134
Dong Ket 101
Lomé 98
Redmond 93
Abidjan 89
Boardman 88
New York 78
Westminster 73
Nanjing 70
Berlin 56
Padova 56
Ho Chi Minh City 55
Los Angeles 55
Turin 48
Hanoi 44
Helsinki 42
Rome 42
Falls Church 41
Milan 41
Jinan 38
Dallas 33
Redondo Beach 33
San Diego 33
Shenyang 33
Abeokuta 29
Sofia 28
Buffalo 26
Jacksonville 26
Hefei 25
Saint Petersburg 25
Amman 24
Frankfurt am Main 24
Brussels 23
Tokyo 22
Vienna 22
Zhengzhou 22
Changsha 21
Hebei 21
Jiaxing 21
Toronto 21
Seoul 20
Tianjin 19
Chicago 18
Dearborn 18
Jakarta 17
Munich 17
Nanchang 17
Warsaw 17
Bremen 16
Hangzhou 16
Phoenix 16
São Paulo 16
Norwalk 15
San Francisco 15
Guangzhou 14
Hyderabad 14
Kuban 13
Ravenna 13
Shanghai 13
Taizhou 13
Des Moines 12
Medford 12
Florence 11
London 11
Orem 11
Taiyuan 11
Redwood City 10
Yubileyny 10
Wuhan 9
Haikou 8
Haiphong 8
Monmouth Junction 8
Montreal 8
Mülheim 8
Ningbo 8
Salt Lake City 8
Zanjan 8
Amsterdam 7
Cesena 7
Denver 7
Düsseldorf 7
Kuala Lumpur 7
Lappeenranta 7
Totale 7.735
Nome #
Follow-up del cancro del pancreas esocrino 401
A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and high-resolution genomic copy number. 241
A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach 230
18F-FDG-PET/CT imaging in cardiac tumors: illustrative clinical cases and review of the literature. 211
Molecular modelling evaluation of exon 18 His845_Asn848delinsPro pDGFRα mutation in a metastatic GIST patient responding to imatinib 209
Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST. 208
Chronic therapy in gastrointestinal stromal tumours (GISTs): the big gap between theory and practice 199
Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations 192
An exploratory association of polymorphisms in angiogenesis-related genes with susceptibility, clinical response and toxicity in gastrointestinal stromal tumors receiving sunitinib after imatinib failure 190
Evaluation of extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced epithelial ovarian cancer. 187
Genome-wide analysis identifies MEN1 and MAX mutations and a neuroendocrine-like molecular heterogeneity in Quadruple WT GIST 187
Whole Exome Sequencing Uncovers Germline Variants of Cancer-Related Genes in Sporadic Pheochromocytoma 186
Alternative schedules or integration strategies to maximise treatment duration with sunitinib in patients with gastrointestinal stromal tumours. 185
Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST) 182
Diagnostic Accuracy of Cardiac Computed Tomography and 18F-Fluorodeoxyglucose With Positron Emission Tomography in Cardiac Masses 180
Duration of adjuvant treatment following radical resection of metastases from gastrointestinal stromal tumours. 176
Development of a Nephrotic Syndrome in a Patient with Gastrointestinal Stromal Tumor during a Long-Time Treatment with Sunitinib. 175
Late recurrences of gastrointestinal stromal tumours (GISTs) after 5 years of follow-up. 174
Integrated Molecular Characterization of Gastrointestinal Stromal Tumors (GIST) Harboring the Rare D842V Mutation in PDGFRA Gene. 174
Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST) 173
Mechanisms of secondary resistance to tyrosine kinase inhibitors in gastrointestinal stromal tumours (Review). 171
An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor 171
Successful multidisciplinary clinical approach and molecular characterization by whole transcriptome sequencing of a cardiac myxofibrosarcoma: A case report 170
Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST 169
Severe esophagitis in a patient with gastrointestinal stromal tumor treated with imatinib. 165
Differential expression of neural markers in KIT and PDGFRA wild-type gastrointestinal stromal tumours. 163
HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma 162
Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice 160
Insulin-like growth factor 1 receptor expression in wild-type GISTs: a potential novel therapeutic target. 159
Identification of an actionable mutation of kit in a case of extraskeletal myxoid chondrosarcoma 158
MicroRNA profile in gastrointestinal stromal tumors (GISTs) and correlation with KIT/PDGFRA kinase genotype. 155
Integrating miRNA and gene expression profiling analysis revealed regulatory networks in gastrointestinal stromal tumors 152
Successful treatment with personalized dosage of imatinib in elderly patients with gastrointestinal stromal tumors 152
Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib 152
Microscopic margins of resection influence primary gastrointestinal stromal tumor survival. 147
Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response 146
Successful radiotherapy for local control of progressively increasing metastasis of gastrointestinal stromal tumor. 144
Gastrointestinal stromal tumors: report of an audit and review of the literature. 144
Gene Expression Profiling of PDGFRA Mutant GIST Reveals Immune Signatures as a Specific Fingerprint of D842V Exon 18 Mutation 142
Surgical second-look in high risk gastrointestinal stromal tumor of small intestine: A case report. 139
Case Report: The Complete Remission of a Mixed Germ Cell Tumor With Somatic Type Malignancy of Sarcoma Type With a GCT-Oriented Therapy: Clinical Findings and Genomic Profiling 134
Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma 133
Integrative analysis of gene expression profiling and high-resolution genomic copy number in gastrointestinal stromal tumor (GIST). 133
Molecular characterization of metastatic exon 11 mutant gastrointestinal stromal tumors (GIST) beyond KIT/PDGFRα genotype evaluated by next generation sequencing (NGS) 131
Microscopic margins of resection in gastrointestinal stromal tumor (GIST): An analysis of 122 patients 131
Management of patients with gastrointestinal stromal tumor in clinical practice in Italy: a critical "event tree model" analysis of decision-making processes and outcomes. 131
Radiotherapy in the management of gist: state of the art and new potential scenarios 129
Primary malignant pericardial tumour in Lynch syndrome 127
Surgical debulking of gastrointestinal stromal tumors: is it a reasonable option after second-line treatment with sunitinib? 126
Genetic aberrations and molecular biology of cardiac sarcoma 125
Paratesticular Mesenchymal Malignancies: A Single-Center Case Series, Clinical Management, and Review of Literature 124
CRITICAL ANALYSIS ON MANAGEMENT OF GIST PATIENTS WITH EVENT TREE MODEL 123
Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable Gastrointestinal stromal tumours treated with imatinib therapy 123
What is changing in the surgical treatment of gastrointestinal stromal tumors after multidisciplinary approach? A comprehensive literature's review 123
Successful selective arterial embolizations for bone metastases in renal cell carcinoma integrated with systemic therapies: A case report 123
SDHA and SDHB mutations in KIT/PDGFRA WT gastrointestinal stromal tumors 123
Complete radiological response to first-line regorafenib in a patient with abdominal relapse of BRAF V600E mutated GIST 123
Doxorubicin plus dacarbazine (DTIC) in advanced solitary fibrous tumor (SFT): An Italian retrospective case series analysis. 120
Impressive long-term disease stabilization by nilotinib in two pretreated patients with KIT/PDGFRA wild type metastatic gastrointestinal stromal tumors. 119
The follow-up issues: from the necessity to the opportunity 117
The potential role of IGF1r in young adult patients with gastroinetstinal stromal tumor (GIST). 112
Current status of the adjuvant therapy in uterine sarcoma: A literature review 112
(Neo)adjuvant treatment in localised soft tissue sarcoma: The unsolved affair 111
Pharmacological therapies for Liposarcoma 111
Treatments for gastrointestinal stromal tumors that are resistant to standard therapies 99
null 98
Dystrophin deregulation is associated with tumor progression in KIT/PDGFRA mutant gastrointestinal stromal tumors. 93
Granular cell tumor of the trachea as a rare cause of dyspnea in a young woman 91
Targeted Deep Sequencing Uncovers Cryptic KIT Mutations in KIT/PDGFRA/SDH/RAS-P Wild-Type GIST 90
null 90
The safety and efficacy of trabectedin for the treatment of liposarcoma or leiomyosarcoma 89
Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour 88
null 87
Targeted therapies in solid tumours: results and promises 83
Prolonged activity and toxicity of sirolimus in a patient with metastatic renal perivascular epithelioid cell tumor: A case report and literature review 83
GASTROINTESTINAL STROMAL TUMORS: A MONOISTITUTIONAL EXPERIENCE. 81
Polymorphisms in DNA repair genes in gastrointestinal stromal tumours: susceptibility and correlation with tumour characteristics and clinical outcome 71
null 70
Recurrent Uterine Smooth-Muscle Tumors of Uncertain Malignant Potential (STUMP): State of The Art 69
Development and Management of Massive Subcutaneous Metastases with Unusual Clinical Course from Uterine Leiomyosarcoma 65
Case Report: The Complete Remission of a Mixed Germ Cell Tumor With Somatic Type Malignancy of Sarcoma Type With a GCT-Oriented Therapy: Clinical Findings and Genomic Profiling 57
Identification of SRF-E2F1 fusion transcript in EWSR-negative myoepithelioma of the soft tissue 49
Three cases of bone metastases in patients with gastrointestinal stromal tumors 47
Targeted therapies in gastrointestinal stromal tumours (GIST): Results and promises 36
Erratum: Microscopic margins of resection influence primary gastrointestinal stromal tumor survival (Onkologie (2012) 35 (645-648)) 30
Safety and Activity of Immune Checkpoint Inhibitors in People Living with HIV and Cancer: A Real-World Report from the Cancer Therapy Using Checkpoint Inhibitors in People Living with HIV-International (CATCH-IT) Consortium 24
Totale 11.735
Categoria #
all - tutte 32.694
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.694


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021627 0 0 0 0 0 60 17 68 148 47 44 243
2021/20221.682 139 72 72 116 150 95 47 129 80 114 370 298
2022/20232.000 234 320 108 246 108 128 46 107 304 58 150 191
2023/2024523 48 90 24 69 29 112 13 57 6 24 26 25
2024/20251.713 85 244 160 148 283 97 132 87 29 115 54 279
2025/20261.864 342 246 277 259 515 225 0 0 0 0 0 0
Totale 11.735